PP
ITCI

PDT Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

PDT Partners’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35,218
Closed -$2.41M – 845
2024
Q2 		$2.41M Sell
35,218
-15,714
-31% -$1.09M 0.23% 158
2024
Q1 		$3.52M Sell
50,932
-7,406
-13% -$509K 0.33% 83
2023
Q4 		$4.18M Sell
58,338
-12,114
-17% -$697K 0.46% 45
2023
Q3 		$3.67M Buy
70,452
+14
+0% +$816 0.46% 45
2023
Q2 		$4.46M Sell
70,438
-9,428
-12% -$587K 0.61% 16
2023
Q1 		$4.32M Buy
79,866
+24,657
+45% +$1.19M 0.59% 7
2022
Q4 		$2.92M Buy
55,209
+41,716
+309% +$2.09M 0.47% 30
2022
Q3 		$628K Buy
+13,493
New +$705K 0.1% 365
2020
Q1 		– Sell
-6,229
Closed -$214K – 885
2019
Q4 		$214K Sell
6,229
-123,512
-95% -$1.48M 0.01% 631
2019
Q3 		$969K Buy
129,741
+84,537
+187% +$811K 0.06% 285
2019
Q2 		$587K Buy
+45,204
New +$580K 0.03% 295
2018
Q2 		– Sell
-115,700
Closed -$2.44M – 589
2018
Q1 		$2.44M Sell
115,700
-18,254
-14% -$356K 0.08% 247
2017
Q4 		$1.94M Buy
133,954
+66,154
+98% +$1.02M 0.06% 305
2017
Q3 		$1.07M Sell
67,800
-10,300
-13% -$151K 0.04% 348
2017
Q2 		$970K Sell
78,100
-13,084
-14% -$152K 0.04% 344
2017
Q1 		$1.48M Sell
91,184
-173
-0.2% -$2.5K 0.08% 268
2016
Q4 		$1.38M Buy
+91,357
New +$1.29M 0.09% 290

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PDT Partners's ITCI Position: Q3 2024 in Review

PDT Partners sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2024, closing a stake of 35,218 shares — an estimated $2.41M sold.

PDT Partners first reported a position in ITCI in Q4 2016 and held it in 17 quarters. The position peaked at $4.46M in Q2 2023. 354 funds tracked by Wall St. Rank hold ITCI as of Q3 2024.

  • PDT Partners reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2024 after selling out during the quarter.
  • PDT Partners sold 35,218 Intra-Cellular Therapies Inc. shares in Q3 2024, an estimated $2.41M.
  • PDT Partners first reported a position in Intra-Cellular Therapies Inc. in Q4 2016 and held it in 17 quarters.
  • PDT Partners's Intra-Cellular Therapies Inc. position peaked at $4.46M in Q2 2023.
  • 354 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2024.

Based on PDT Partners's 13F filing for Q3 2024, filed 14 Nov 2024.